| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/28/2006 | WO2006100089A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 09/28/2006 | WO2006099706A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 09/28/2006 | WO2006073602A9 Rnai modulation of the bcr-abl fusion gene and uses thereof |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2005047315A3 Optimized expression of hpv 58 l1 in yeast |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | WO2004080404A3 Il-2 transmembrane constructs |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217341 DNA vaccine formulations |
| 09/28/2006 | US20060217340 Methods and products for treating hypertension by modulation of TRPC3 channel activity |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217338 Influenza nucleic acids, polypeptides, and uses thereof |
| 09/28/2006 | US20060217337 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217336 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 09/28/2006 | US20060217335 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217334 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217333 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function |
| 09/28/2006 | US20060217332 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 09/28/2006 | US20060217331 Chemically modified double stranded nucleic acid molecules that mediate RNA interference |
| 09/28/2006 | US20060217330 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs |
| 09/28/2006 | US20060217329 Therapeutic uses of inhibitors of RTP801 |
| 09/28/2006 | US20060217328 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders |
| 09/28/2006 | US20060217327 Sirna expression system |
| 09/28/2006 | US20060217326 Group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
| 09/28/2006 | US20060217325 Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells |
| 09/28/2006 | US20060217324 RNAi modulation of the Nogo-L or Nogo-R gene and uses thereof |
| 09/28/2006 | US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care |
| 09/28/2006 | US20060217298 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 09/28/2006 | US20060217294 Compounds binding to p-selectin |
| 09/28/2006 | US20060217289 Administering a polypeptide having an oxime-containing non-natural amino acid, from a translation system of: a polynucleotide comprising a selector codon encoding the polypeptide, a tRNA comprising the oxime-containing amino acid |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216748 Genes differentially expressed in breast cancer |
| 09/28/2006 | US20060216747 first nucleotide sequence complementary to a target RNA sequence or a portion thereof, and a second sequence chemically modified so that it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; pharmaceutical use such as viricide |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216733 Eubacterial tmRNA sequences and uses thereof |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216705 Transcription activation complex and utilization thereof |
| 09/28/2006 | US20060216343 Pharmaceutical compositions comprising an oligonucleotide as an active agent |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216315 Cockroach allergen gene expression and delivery systems and uses |
| 09/28/2006 | US20060216311 Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA |
| 09/28/2006 | US20060216309 Identification of genes |
| 09/28/2006 | US20060216308 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 09/28/2006 | US20060216299 Cell cycle targets and peptides |
| 09/28/2006 | US20060216297 Method and composition for reducing blood sugar levels or fat storage by targeting cathepsin |
| 09/28/2006 | US20060216296 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/28/2006 | US20060216295 Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy |
| 09/28/2006 | US20060216292 Treatment of neurodegenerative diseases |
| 09/28/2006 | US20060216290 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (Par1) |
| 09/28/2006 | US20060216287 EPH-like receptor protein tyrosine kinases |
| 09/28/2006 | US20060216283 Inhibition of secretion from non-neuronal cells |
| 09/28/2006 | US20060216282 administering antibodies or fragments that binds to kit proteins (glycoprotein receptor protein-tyrosine kinase), to inhibit the kinase enzymatic reactions and to inhibit the stem cell factor signal transduction; treatment of skin disorders, asthma, inflammation, anaphylaxis, bronchospasm and tumors |
| 09/28/2006 | US20060216278 Entrapped stem cells and uses thereof |
| 09/28/2006 | US20060216277 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 09/28/2006 | US20060216275 Apparatus and method for pre-conditioning/fixation and treatment of disease with heat activation/release with thermoactivated drugs and gene products |
| 09/28/2006 | US20060216274 Induction of immune response to antigens expressed by recombinant adeno-associated virus |
| 09/28/2006 | US20060216273 Gene therapy for colorectal cancer |
| 09/28/2006 | US20060216272 Therapeutic immunization of hiv-infected individuals |
| 09/28/2006 | US20060216271 Synergistic combination of two adenoviral vectors that are replication incompetent cotranscomplements of each other and one is recombinant 1014; enhances both gene delivery and gene expression of genetic sequences contained within the vector. |
| 09/28/2006 | US20060216269 Dendritic cell tumor injection (DCTI) therapy |
| 09/28/2006 | US20060216242 Suspending vehicles and pharmaceutical suspensions for drug dosage forms |
| 09/28/2006 | US20060216238 Compositions and methods for targeting or imaging a tissue in a vertebrate subject |
| 09/28/2006 | US20060216232 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 09/28/2006 | US20060216231 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 09/28/2006 | DE19917195B4 Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor Peptide to induce an immune response against tumor cells containing this pharmzeutische compositions, uses thereof, nucleic acid coding therefor and these nucleic acid expression vector containing |
| 09/28/2006 | DE102005014083A1 Kolloidale Nanokomposite aus LbL-Partikeln, Lipiden und biologischen Komponenten angewandt in Medizin, Molekularbiologie und Diagnostik Colloidal Nanocomposites of LbL particles, lipids and biological components used in medicine, molecular biology and diagnostics |
| 09/28/2006 | CA2602925A1 Methods for treating tumors and cancerous tissues |
| 09/28/2006 | CA2602676A1 Seneca valley virus based compositions and methods for treating disease |
| 09/28/2006 | CA2602182A1 Influenza therapeutic |
| 09/28/2006 | CA2601855A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 09/28/2006 | CA2601373A1 Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
| 09/28/2006 | CA2570563A1 Method for screening agents against human prostate disease |
| 09/27/2006 | EP1705248A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1704250A2 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 09/27/2006 | EP1704243A2 Oligonucleotide compound and method for treating nidovirus infections |
| 09/27/2006 | EP1268759B1 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/27/2006 | EP1180016B1 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 09/27/2006 | CN1839201A Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| 09/27/2006 | CN1838966A Use of human growth hormone in multiple system atrophy |
| 09/27/2006 | CN1838962A Injection of bone marrow-derived cells and medium for angiogenesis |
| 09/27/2006 | CN1837367A SiRNA sequence directing towards influenza B virus membrane protein gene and its application |
| 09/27/2006 | CN1837366A SiRNA sequence directing towards influenza B virus polymerase gene and its application |
| 09/27/2006 | CN1837365A SiRNA sequence directing towards influenza B virus nucleocapsid gene and its application |
| 09/27/2006 | CN1837362A SiRNA for inhibiting expression of SARS coronavirus N protein and encoding gene thereof |
| 09/27/2006 | CN1836732A Two kinds of novel angiogenesis-inhibiting medicine and its uses in preventing and treating tumour |
| 09/27/2006 | CN1276974C Gsk3 polypeptides |
| 09/27/2006 | CN1276778C SARS nucleic acid vaccine and preparation method |
| 09/27/2006 | CN1276777C SARS vaccine of adenovirus vector and preparation method, application of coronavirus S gene |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | US7112668 Polypeptides and nucleic acids encoded thereby |
| 09/26/2006 | US7112667 Sequences of an Ih ion channel and use thereof |
| 09/26/2006 | US7112666 Von Willebrand Factor (Vwf)-cleaving protease |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/26/2006 | US7112442 Tryptophan containing low molecular weight polylysine, for use in receptor-mediated and nonreceptor-mediated gene delivery, both in vivo and in vitro |
| 09/26/2006 | US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |